Tilray | TRLY - Interest Income


Tilray reported $12.83M in Interest Income for its fiscal quarter ending in May of 2024.





Interest Income Change Date
Acasti Pharma USD -0.36 172K Dec/2024
Aurora Cannabis CAD 1.04M 808K Mar/2026
Canopy Growth CAD 3.86M 1.89M Mar/2026
Cronos Group USD 8.85M 706K Mar/2026
Dianthus Therapeutics USD 6.26M 2.61M Mar/2026
Ionis Pharmaceuticals USD -0.66 0.29 Dec/2024
IQVIA Holdings USD 7M 3M Jun/2026
Knight Therapeutics CAD 2.46M 498K Sep/2024
Moderna USD 72M 2M Mar/2026
Revvity USD 6.3M 552K Mar/2026
Tectonic Therapeutic USD 1.74M 217K Dec/2024
Tilray USD 12.83M 20.19M May/2024
Xeris Pharmaceuticals USD 1.2M 44K Mar/2026
Zealand Pharma A/S 74M 28.41M Mar/2026